PRODUCT TYPES – Page 35 – Pharma.Tips

Sterility assurance gap during radiopharma production: regulatory deviation handling

The first step in addressing a sterility assurance gap is to identify the symptoms or signals indicating a potential issue. These signs may manifest as:Click to read the full article.

Finished product nitrosamine risk assessment gap during recall risk assessment: how to build a deviation package that passes an inspection deep-dive

Identifying the signs of a possible nitrosamine risk assessment gap is the first step in a successful investigation. Symptoms may manifest as deviations, Out of Specification (OOS) results, or unexpected…

Stability failure in veterinary product manufacturing: regulatory communication strategy

Identifying symptoms or signals early is crucial in managing a stability failure. Symptoms can manifest in several ways:Click to read the full article.

Stability failure during regulatory submission: GMP investigation and CAPA

Identifying symptoms early is crucial to mitigating impacts associated with stability failures. Common signals that may indicate a potential stability failure include:Click to read the full article.

Biologic stability failure (real-time/accelerated) during PPQ / process validation: single-use systems risk controls, leachables review, and supplier oversight actions

The first step in an investigation of biologic stability failures during process validation is identifying the symptoms or signals. These may present as:Click to read the full article.

Stability failure during regulatory submission: regulatory communication strategy

Identifying the symptoms or signals of stability failures is critical to initiating an effective investigation. Common indicators include:Click to read the full article.

Residue limit non-compliance during inspection prep: risk assessment for animal and food safety

Identifying symptoms of residue limit non-compliance begins with vigilant observation and monitoring in both manufacturing and laboratory environments. Common indicators may include:Click to read the full article.

Residue limit non-compliance during regulatory submission: risk assessment for animal and food safety

The initial identification of residue limit non-compliance often occurs through various signaling mechanisms, either on the production floor or within laboratory analyses. Key symptoms include:Click to read the full article.

Assay OOS in veterinary product manufacturing: GMP investigation and CAPA

In the context of veterinary product manufacturing, the identification of assay OOS is critical in recognizing potential product quality issues. Common symptoms include:Click to read the full article.

Residue limit non-compliance in veterinary product manufacturing: regulatory communication strategy

Recognizing early signals of residue limit non-compliance is essential to an effective investigation. Symptoms may arise from various sources, including analytical testing results, batch quality discrepancies, or external complaints from…

Stability failure during inspection prep: risk assessment for animal and food safety

Detecting symptoms or signals of stability failures requires vigilance across various stages of production and quality control. Some common indicators include:Click to read the full article.

Microbial limits failure in veterinary product manufacturing: GMP investigation and CAPA

The initial signs of microbial limits failure may manifest in several ways during the routine quality control processes. Common symptoms include:Click to read the full article.